While it’s been a rocky year for many, everything is smooth sailing at Kriya Therapeutics—one of biotech’s top money raisers last year—as it continues its acquisition streak. This time, Kriya has ...
Gene therapy biotech Kriya Therapeutics is continuing its acquisition streak to build out a pipeline, this time with a focus on the brain. The North Carolina-based biotech is buying Redpin ...
Kriya Payments is now available in 42 countries. This means buyers worldwide can “take advantage of flexible payment terms, feeling more secure about their cash flow.” General Manager, Martina ...
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated gene therapy company pioneering novel technologies and therapeutics, today announced ...
REDWOOD CITY, Calif. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kriya Therapeutics, Inc., a fully integrated platform company pioneering novel technologies and therapeutics in gene therapy, ...
Kriya Therapeutics has closed an oversubscribed Series D funding round, raising $320m, aimed at propelling its gene therapy pipeline targeting chronic diseases with significant unmet medical needs.
Please provide your email address to receive an email when new articles are posted on . Kriya Therapeutics Inc. announced the acquisition of biotech company Redpin Therapeutics Inc., bolstering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback